Plenty of announcements due - pre-clinical cancer immunity study...

Plenty of announcements due - pre-clinical cancer immunity study results were due in June so are expected any day now. There are also final reports into the phase I cancer (nearing completion of the continuous infusion trial) and the phase I psoriasis trials which will give a strong indication of efficiacy and potential of their drug. There is also an ex-vivo tumour testing program of Coramsine in the USA on “real” cancer cells from patients to determine the most sensitive target tumours that best respond to Coramsine alone or in combination with other treatment regimes. Findings from all this work will be known anytime between now and the next 1-2 months (right before Septembers next option truncation from 20 to 30c).